Testing the Effectiveness of Two Hospitalization Alternatives Compared to Psychiatric Hospitalization (HOSP-ALT)
NCT05431231 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2022-06-24
Summary
studies show that many of the people who were hospitalized in psychiatric wards had negative experiences of their stay there. These reports regarding patients' experiences have led in recent years to the development of several hospitalization alternatives that were meant to improve patients' experiences in an acute time in their lives, out of hope that the staying in a familiar and safe place and in one's natural environment will allow better recovery. The current study, is an open comparative study. Testing the effectiveness of two hospitalization alternatives compared to psychiatric hospitalization. First alternative is called Soteria. a house in the community for people who are coping with extreme emotional states. The goal of the house is to allow the coping person to get through the crisis in an open, respectful atmosphere. Second alternative is online home hospitalization. The model uses technological solutions to allow management of effective, integrative treatment for people who are coping with extreme emotional states while they remain in their homes. this model is innovative and has not yet been attempted elsewhere in the world. The goal of the current study is to explore whether there are any differences between hospitalization in psychiatric units, online home hospitalization, and staying in Soteria homes in a series of qualitative, outcome and process measures.
Conditions
- Questionnaires
- Data Collection
Interventions
- DIAGNOSTIC_TEST
-
Outcome Questionnaire-45
a questionnaire that evaluates the patient's level of distress. The questionnaire was developed by Lambert et al. in 1996 and was translated to Hebrew by Gross, Glasser, Elisha et al. in 2015. The questionnaire is composed of 45 statements that describe emotional states, assessing three main components: subjective discomfort, interpersonal relationships and performance of social roles. The participants are asked to rate how often they have felt the states described by each statement using a five-level Likert scale (0 - never, 4 - almost always). This questionnaire has been used extensively and has showed good internal consistence of 0.93 for its English version and 0.91 for its Hebrew version.
- DIAGNOSTIC_TEST
-
Hopkins symptoms checklist - short form
a questionnaire for assessing symptomatic distress. The questionnaire was developed by Lutz, Tholen, Schürch, and Berking in 2006. It is a short version of the SCL-90-R, that was developed by Derogatis in 1992. The checklist includes 11 items that describe negative feelings and thoughts. Participants are asked to rate the extent to which a given feeling or thought has troubled them in the past week using a four-level Likert scale (1 - not at all, 4 - very much). This tool is highly correlated with the Global Severity Index (r=.91) and has shown high internal consistency.
- DIAGNOSTIC_TEST
-
Prodromal Questionnaire - Brief Version
a patient questionnaire that assesses the existence of a prodromal state or fully developed psychosis. It was developed by Ising et al. in 2012 and was translated to Hebrew by Koren et al. in 2016. The tool is based on a more extensive questionnaire - PQ-92 - that was developed by Loewy et al. in 2005 - and constitutes an attempt to create an improved shorter version. The PQ-16 includes 16 items that refer to thoughts, feelings and experiences that describe various symptoms, including abnormal perception (9 items), unconventional thinking and paranoia (5 items) and negative symptoms (2 items). For each item, first, the participant is asked to indicate whether he had experienced that phenomenon in the past month, and if he had, he is asked to describe the extent to which the phenomenon had caused him distress, using a four-level Likert scale (0 - no distress, 3 - severe distress). Ising et al. found that Kronbach's α was 0.774 for the whole questionnaire.
- DIAGNOSTIC_TEST
-
Manchester Short Assessment of Quality
a patient questionnaire that assesses quality of life. This questionnaire was developed by Priebe, Huxley, Knight and Evans in 1999. It is based on a longer questionnaire - Lancashire Quality of Life Profile (LQLP) - and was created as an attempt to form an improved shorter version. The questionnaire is composed of two parts: personal details that can change over time and 16 questions that assess objective and subjective quality of life. The objective items are presented as yes or no questions, while regarding the subjective items, participants are asked to describe, using a 7-level Likert scale, the extent to which they are satisfied with their lives. Priebe et al. reported an alpha internal consistency of 0.74.
- DIAGNOSTIC_TEST
-
Self-Stigma of Mental Illness Scale
a patient questionnaire that assesses internalized self-stigma. It was developed by Corrigan, Watson, and Barr in 2006. The questionnaire is composed of four dimensions. The questionnaire includes 40 items, 10 items for each dimension. The participant is asked to rate the extent to which he agrees with each item using a 9-level Likert scale. The questionnaire yields four separate scores for each dimension, and each dimension can be administered separately and independently. In the current study, only one 10-item dimension will be administered - the extent to which the participant has internalized stereotypes concerning mental illness. Corrigan et al (2006) reported an internal consistency alpha of 0.81 and a test-retest reliability ratio of 0.82 for this dimension.
- DIAGNOSTIC_TEST
-
Session Alliance Inventory - for patient
this questionnaire has two versions, one for patients and one for the main therapist in the therapeutic team, and its goal is to evaluate the therapist-patient relationship (therapeutic alliance). It is composed of 6 statements that relate to the therapeutic relationship. The participants are asked to rate the extent to which the statements describe their experience accurately using a 7-level Likert scale (1 - does not describe my experience in any way, 7 - describes my experience exactly). In the current study, patients will define who their main therapist is. Falkenstrom et al. reported that in their three tested samples, the alpha coefficients ranged from 0.89 to 0.94.
- OTHER
-
Quality of service/satisfaction questionnaire
measured by the quality of service department at Sheba Medical Health Center (or - PROMS, to be decided). Here customer's experience of the online services would be measured as well.
- DIAGNOSTIC_TEST
-
Clinical decision-making style
a questionnaire with two - patient and therapist - versions, meant to evaluate decision making style. It was developed by Puschner, Neumann, Jordan, et al. in 2013. The questionnaire constitutes a modified version of the Autonomy Preference Index (API), which was developed by Ende, Kazis, Ash, \& Moskowitz in 1989 for mental health patients. In the current study, only the therapist/psychiatrist version would be administered. The questionnaire is composed of 21 items and yields two components related to clinical decision making: preferences in decision making style and information seeking during decision making. Puschner et al (2013) reported that Kronbach's α coefficient ranged from 0.87 to 0.89.
- DIAGNOSTIC_TEST
-
Global Assessment of Functioning Scale
a questionnaire meant to assess the patient's global functioning. It was developed by Jones, Thornicroft, Coffey, \& Dunn in 1996. The GAF was used in DSM-IV as the fifth axis of psychiatric evaluation. The therapist is asked to determine for each patient a general score ranging from 10 to 100 to describe his everyday functioning in psychological, social and occupational fields. A score of 10 refers to a state of persistent danger of severely hurting the self or others, and a score of 100 refers to superior functioning in all areas of life. Jones et al. reported that Kronbach's α ranged from 0.74 to 0.76.
- DIAGNOSTIC_TEST
-
Session Alliance Inventory - for therapist
a questionnaire that has two - patient and therapist - versions, meant to assess the therapist-patient relationship (therapeutic alliance). It was developed by Falkenstrom, Hatcher, Skjulsvik, Larsson, \& Holmqvist in 2014. Each questionnaire (patient/therapist) is composed of 6 statements that refer to the therapeutic relationship. The participants are asked to rate the extent to which the statements describe their experience accurately using a 7-level Likert scale (1 - does not describe my experience in any way, 7 - describes my experience exactly). Falkenstrom et al reported that Kronbach's α coefficient ranged from 0.89 to 0.94 for their three tested samples. In the current study, patients will define who their main therapist is.
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-12
- Primary Completion
- 2023-02-28
- Completion
- 2024-02-29
Countries
- Israel
Study Locations
More Related Trials
-
Psychiatric Consultation Through Videoconference in a Primary Care Setting
NCT00298961 ·Status: UNKNOWN ·Phase: NA
-
Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile
NCT03197168 ·Status: COMPLETED ·Phase: NA
-
Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients
NCT04314154 ·Status: UNKNOWN
-
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness
NCT04551027 ·Status: UNKNOWN ·Phase: NA
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Quality of Life in Schizophrenic Patients
NCT00597168 ·Status: COMPLETED
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs
NCT00514423 ·Status: COMPLETED ·Phase: NA
-
Altitudes: A Digital Intervention to Support Caregivers
NCT06509100 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effectiveness of Psychiatric Interventions on the Inpatient Unit
NCT03626142 ·Status: ENROLLING_BY_INVITATION
-
Shared Decision Making for Antipsychotic Medications
NCT05416658 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)
NCT00753051 ·Status: COMPLETED ·Phase: NA
-
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
NCT06182787 ·Status: RECRUITING
-
Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
NCT01611337 ·Status: COMPLETED ·Phase: NA
-
Psychotherapy and Pharmacotherapy in Dissociative Disorders
NCT00630981 ·Status: UNKNOWN
-
Health Outcomes Via Positive Engagement in Schizophrenia
NCT04230590 ·Status: UNKNOWN
-
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
NCT00169091 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Home Treatment for Acute Psychiatric Care
NCT03320720 ·Status: UNKNOWN ·Phase: NA
-
Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P)
NCT07093671 ·Status: RECRUITING ·Phase: NA
-
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01164059 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)
NCT00156065 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
NCT01448499 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Adherence Therapy for Schizophrenia
NCT01780116 ·Status: COMPLETED ·Phase: PHASE1/PHASE2